BILL · 2021–22 SESSION
SB 5822: Biomarker testing coverage
Concerning insurance coverage for biomarker testing.
Summary
- Requires insurance coverage for biomarker testing when supported by medical and scientific evidence.
From the Senate Bill Report (Orig.) (SB 5822), written by the Legislature's nonpartisan staff. Read the full report ↗
Did not pass Did not pass · died in committee
- IntroducedJan 12, 2022
- Out of committeestopped here
- Passed Senate
- Passed House
- Governor
- Law
- Prime sponsor
- Lynda Wilson (R-17)
- Introduced
- January 12, 2022 in the Senate
- Last action
- January 12, 2022
- Budget
- Has a fiscal note
AN ACT Relating to insurance coverage for biomarker testing;
Sponsors
Prime sponsor: Lynda Wilson (R-17)
6 co-sponsors (3 Democrats, 3 Republicans)
Votes
No recorded floor votes. This measure never reached a floor vote.
History
- First reading, referred to Health & Long Term Care.
SB 5822 in other sessions
Bill numbers restart every two years, so the same number is a different bill in each session.
- SB 5822 (2025–26) Missing persons alert system
- SB 5822 (2023–24) Physicians health prg. fees
- SB 5822 (2019–20) Universal health care system
- SB 5822 (2017–18) Workers' compensation system
- SB 5822 (2015–16) Pharmacy provisions
- SB 5822 (2013–14) Child abuse or neglect
- SB 5822 (2011–12) SR 9 Snohomish river bridge
- SB 5822 (2009–10) Mobile home/landlord-tenant